Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients

Aim. The aim of the study was to assess the association of genetic polymorphisms of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) with atrial fibrillation development in elderly patients with coronary artery disease (CAD), undergoing coronary artery b...

Full description

Bibliographic Details
Main Authors: A. O. Rubanenko, O. A. Rubanenko, L. V. Limareva, Iu. V. Shchukin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2018-11-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2921
_version_ 1797856851268730880
author A. O. Rubanenko
O. A. Rubanenko
L. V. Limareva
Iu. V. Shchukin
author_facet A. O. Rubanenko
O. A. Rubanenko
L. V. Limareva
Iu. V. Shchukin
author_sort A. O. Rubanenko
collection DOAJ
description Aim. The aim of the study was to assess the association of genetic polymorphisms of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) with atrial fibrillation development in elderly patients with coronary artery disease (CAD), undergoing coronary artery bypass graft (CABG) surgery.Material and methods. Studied were 80 patients who underwent CABG in 2015-2016 years. In all the patients routine laboratory and instrumental tests were performed. Patients also underwent genetic polymorphisms of ММР-9 А8202G and TIMP-1 C536T estimation with polymerase chain reaction. According to occurrence of postoperative atrial fibrillation (POAF) all the patients were divided into two groups: 1 group comprised 56 patients without POAF (81,8% males, mean age 65,9±4,0 years), 2 group — 24 patients with first detected episode of AF after CABG (875% males, mean age 67,7±5,4).Results. According to results of multivariate regression analysis the odds ratio of POAF development in patients with stable angina grade III was 1,8 (95% CI 0,5-75, p=0,4), NYHA III — 0,85 (95% CI 0,2-3,5, p=0,55), history of CAD more than 20 months — 1,8 (95% CI 1,2-8,1, p=0,03), LA diameter more than 39 mm — 4,2 (95% CI 1,6-9,5, p<0,0001), allele G MMP-9 A8202G — 2,6 (95% CI 1,2-75, p=0,03). Conclusion. In elderly patients undergoing coronary artery bypass graft surgery left atrial diameter more than 39 mm, history of coronary artery disease more than 20 months and the presence of G allele of MMP-9 A820G are significantly associated with postoperative atrial fibrillation occurrence.
first_indexed 2024-04-09T20:47:07Z
format Article
id doaj.art-effe3d879f8340f0af487ceb57e2f716
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2024-04-09T20:47:07Z
publishDate 2018-11-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-effe3d879f8340f0af487ceb57e2f7162023-03-29T21:23:31Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202018-11-01010485210.15829/1560-4071-2018-10-48-522511Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patientsA. O. Rubanenko0O. A. Rubanenko1L. V. Limareva2Iu. V. Shchukin3Samara state medical universitySamara state medical universitySamara state medical universitySamara state medical universityAim. The aim of the study was to assess the association of genetic polymorphisms of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) with atrial fibrillation development in elderly patients with coronary artery disease (CAD), undergoing coronary artery bypass graft (CABG) surgery.Material and methods. Studied were 80 patients who underwent CABG in 2015-2016 years. In all the patients routine laboratory and instrumental tests were performed. Patients also underwent genetic polymorphisms of ММР-9 А8202G and TIMP-1 C536T estimation with polymerase chain reaction. According to occurrence of postoperative atrial fibrillation (POAF) all the patients were divided into two groups: 1 group comprised 56 patients without POAF (81,8% males, mean age 65,9±4,0 years), 2 group — 24 patients with first detected episode of AF after CABG (875% males, mean age 67,7±5,4).Results. According to results of multivariate regression analysis the odds ratio of POAF development in patients with stable angina grade III was 1,8 (95% CI 0,5-75, p=0,4), NYHA III — 0,85 (95% CI 0,2-3,5, p=0,55), history of CAD more than 20 months — 1,8 (95% CI 1,2-8,1, p=0,03), LA diameter more than 39 mm — 4,2 (95% CI 1,6-9,5, p<0,0001), allele G MMP-9 A8202G — 2,6 (95% CI 1,2-75, p=0,03). Conclusion. In elderly patients undergoing coronary artery bypass graft surgery left atrial diameter more than 39 mm, history of coronary artery disease more than 20 months and the presence of G allele of MMP-9 A820G are significantly associated with postoperative atrial fibrillation occurrence.https://russjcardiol.elpub.ru/jour/article/view/2921elderly patientsatrial fibrillationcoronary artery bypass graftgenetic polymorphismsmatrix metalloproteinase-9tissue inhibitor of matrix metalloproteinase-1
spellingShingle A. O. Rubanenko
O. A. Rubanenko
L. V. Limareva
Iu. V. Shchukin
Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
Российский кардиологический журнал
elderly patients
atrial fibrillation
coronary artery bypass graft
genetic polymorphisms
matrix metalloproteinase-9
tissue inhibitor of matrix metalloproteinase-1
title Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
title_full Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
title_fullStr Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
title_full_unstemmed Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
title_short Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
title_sort genetic polymorphisms of matrix metalloproteinase 9 tissue inhibitor of matrix metalloproteinase 1 and development of postoperative atrial fibrillation in elderly patients
topic elderly patients
atrial fibrillation
coronary artery bypass graft
genetic polymorphisms
matrix metalloproteinase-9
tissue inhibitor of matrix metalloproteinase-1
url https://russjcardiol.elpub.ru/jour/article/view/2921
work_keys_str_mv AT aorubanenko geneticpolymorphismsofmatrixmetalloproteinase9tissueinhibitorofmatrixmetalloproteinase1anddevelopmentofpostoperativeatrialfibrillationinelderlypatients
AT oarubanenko geneticpolymorphismsofmatrixmetalloproteinase9tissueinhibitorofmatrixmetalloproteinase1anddevelopmentofpostoperativeatrialfibrillationinelderlypatients
AT lvlimareva geneticpolymorphismsofmatrixmetalloproteinase9tissueinhibitorofmatrixmetalloproteinase1anddevelopmentofpostoperativeatrialfibrillationinelderlypatients
AT iuvshchukin geneticpolymorphismsofmatrixmetalloproteinase9tissueinhibitorofmatrixmetalloproteinase1anddevelopmentofpostoperativeatrialfibrillationinelderlypatients